Skip to main content
Journal of the Egyptian Public Health Association
Download PDF

The use of multiplex PCR for the detection of atypical pathogens in Egyptian children with CAP: a high rate of Bordetella pertussis in early infancy

Journal of the Egyptian Public Health Association volume 94, Article number: 5 (2019) Cite this article

Abstract

Background

Atypical pathogen infections played an important role in community-acquired pneumonia (CAP) in children. Pathogen-specific clinical symptoms are often lacking, and it is difficult to detect atypical pathogens by culture methods. The use of multiplex polymerase chain reaction (PCR) methods enables testing for many pathogens simultaneously in a single analysis.

Aim

To determine the role of atypical pathogens in children hospitalized with CAP.

Patients and methods

This cross-sectional study was conducted throughout a 2-year period from August 2015 to September 2017. It included 400 Egyptian children hospitalized with clinical diagnosis of CAP at a tertiary hospital in Cairo, Egypt. Sputum samples were collected from lower respiratory tract of all enrolled patients by mucus trap catheter for identification of Bordetella pertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophilia by using multiplex real-time PCR.

Results

Among the 400 CAP patients enrolled in this study, atypical pathogens were detected in 12/400 (3%) patients. Bordetella pertussis was detected in 2% of cases, and it was responsible for CAP in 8/104 (7.69%) infants in the age stratum ≤ 4 months; compared with pertussis-negative cases, pertussis-positive cases were younger and incompletely vaccinated (P values were 0.001 and 0.007, respectively). Mycoplasma pneumoniae was detected in 1% of cases, all were among the age stratum > 4 months ≤ 59 months in 4/272 (1.47%) children.

Conclusion

In early infancy, Bordetella pertussis causes a significant proportion of hospitalized CAP cases; all were ≤ 4 months old and incompletely vaccinated. This finding could suggest the role of maternal immunization in developing countries.

1 Introduction

Pneumonia contributes significantly to global childhood morbidity and mortality. The World Health Organization (WHO) estimates that there are 156 million cases of pneumonia each year in children younger than 5 years, with as many as 20 million cases severe enough to require hospital admission [1].

Atypical pneumonia is used to describe pneumonia caused by atypical pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophili, and others. The clinical course among children infected with these pathogens is different from that of other bacterial or viral infection, most of them progress slowly and have no specific symptoms. Many studies reported that Mycoplasma pneumoniae is the most common atypical pathogen found among children with community-acquired pneumonia (CAP), followed by Chlamydia pneumoniae [2,3,4].

Pertussis (whooping cough) is a respiratory tract infection caused by the Gram-negative bacterium Bordetella pertussis. Pertussis is a highly infectious disease and can cause significant morbidity in infants. Recent evidence shows an appreciable incidence of pertussis among infants presenting with acute pneumonia. In a birth cohort, 2% of clinical pneumonia cases among enrolled infants were caused by pertussis [5]. Another study reported that 3.7% of infants and young children presenting to a tertiary academic hospital had evidence of pertussis infection [6]. Most deaths from pertussis occur in developing countries and among children during the first months of life [7]. The WHO estimated that in 2013, Bordetella pertussis caused approximately 60,257 deaths in children < 5 years of age [8].

Mycoplasma pneumoniae infection shows a variety of clinical manifestations, ranging from asymptomatic infection to fatal pneumonia and may be associated with neurological and systemic symptoms (e.g., rashes). Mycoplasma pneumoniae pneumonia has been reported in 10 to 40% of CAP cases, and children are the most susceptible group to mycoplasma infection [9].

The importance of the atypical pathogens as causative agents of pneumonias is not related to their frequency, but to their difficulty of diagnosis and their non-responsiveness to beta-lactam therapy [10]. Atypical bacteria require specific antibiotic coverage because conventional antibiotics used against typical organisms such as streptococci are not effective. Increasing rates of identification of atypical pathogens as a cause of CAP have been reflected in treatment guidelines favoring antibiotics with atypical coverage for certain patients hospitalized with severe CAP [11].

Investigations of typical pathogens causing CAP in children do not include atypical pathogens because it is difficult to detect them by culture methods [2]. On the other hand, multiplex PCR methods enable testing for several pathogens simultaneously in a single analysis.

So, the aim of this study was to determine the role of Bordetella pertussis, Mycoplasma pneumoniae, Chlamydia pneumonia, and Legionella pneumophilia in community-acquired pneumonia in children using the real-time PCR as the principal method for determination and also to study the relation, if any, between the presence of these pathogens and clinical, laboratory, and radiological variables.

2 Materials and methods

2.1 Study design and subjects

This cross-sectional study was conducted throughout a 2-year period from 1 September 2015 to 31 August 2017. All children fulfilling criteria of case definition of CAP who were hospitalized during this period were enrolled. The study included 400 eligible children, and they were recruited from Emergency Departments of Cairo University Children’s hospitals (The specialized Children Hospital and El Monira Children Hospital), tertiary hospitals that receive patients from all over Egypt. Inclusion criteria were previously healthy children hospitalized with a clinical diagnosis of CAP and patient’s age range from 2 months to 12 years. Exclusion criteria were patients with underlying chronic lung disease, congenital heart disease, immunodeficiency, and chronic hepatic or renal diseases.

3 Methods

Data was collected by full-history taking and meticulous clinical examination of all the studied population. All cases were diagnosed to have pneumonia according to WHO case definition of pneumonia [cough or difficult breathing and respiratory rate more than WHO range for age (respiratory rate ≥ 60 breaths/min for children < 2 months; ≥ 50 breaths/min for children 2–11 months; ≥ 40 breaths/min for children 12–59 months)] [12].

CAP is defined as pneumonia that has been acquired in the community in a patient who has not been hospitalized within 14 days prior to the onset of symptoms or has been hospitalized less than 4 days prior to the onset of symptoms [11]. Criteria for classification as severe pneumonia in children include the following: lethargy, unconsciousness, convulsions, inability to drink, vomiting, and lower chest wall indrawing [13].

3.1 Clinical specimens

Complete blood count (CBC) was determined at the time of study enrollment for each patient. Sputum samples (2 ml) were collected from the lower respiratory tract of all enrolled patients by using mucus trap catheter after sputum induction. The samples were transported to the laboratory in an ice container and stored at − 70 °C.

3.2 Molecular identification by real-time PCR

Molecular detection of Bordetella pertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophilia was done by multiplex real-time PCR using AnyplexTM II RB5 Kit (Cat. No. RB7500Y, Seegene, Korea), operated on Biorad CFX 96 real time machine, according to the manufacturer’s instructions [14,15,16].

Pre-treatment of specimen was done by adding saline solution with the specimen (1:2), vortexed for 1 min, then incubated for 20 min at room temperature.

Conditions and cycles of RT PCR were as follows:

Segment

No. of cycles

Temperature

Duration

1

1

50 °C

4 min

2

1

95 °C

15 min

3

30

95 °C

30 s

4

60 °C

1 min

5

72 °C

30 s

6

1

55 °C

30 s

7

1

Melting curve 55 ~ 85 °C (5 s/0.5 °C)

8

10

95 °C

30 s

9

60 °C

1 min

10

72 °C

30 s

11

1

55 °C

30 s

12

1

Melting curve 55 ~ 85 °C (5 s/0.5 °C)

13

10

95 °C

30 s

14

60 °C

1 min

15

72 °C

30 s

16

1

55 °C

30 s

17

1

Melting curve 55 ~ 85 °C (5 s/0.5 °C)

RB5 PC-positive control included in the kit was used in each run. It contains mixture of pathogen clones. Also, internal control was added to each sample from the start to ensure high-quality amplification occurred for every sample. The RB5 internal control (IC) controlled not only the nucleic acid isolation procedure but also the possibility of PCR inhibition. Ten microliters of the RB5 IC was added to each specimen before the nucleic acid extraction. Nucleic acid isolation was done using Ribo_spinvRD kit (Cat. No302-150SG1701) from GeneAll.

3.3 Statistical analysis

Data was subjected to computer-assisted statistical analysis using statistical package for social science program IBM SPSS (Statistical Package for the Social Science; IBM Corp, Armonk, NY, USA) release 22 for Microsoft Windows. Nominal data was expressed as frequency and percentage and was compared using chi-square test. Numerical data was expressed as mean ± standard deviation and was compared using T test. Non-parametric data was expressed as median “interquartile range” and was compared using Mann-Whitney U test. Associations between numerical variables were studied using Pearson’s correlation. P values less than 0.05 were considered significant.

3.4 Ethical considerations

This study was approved by Cairo University Clinical Research Ethics Committee, and informed verbal consents were obtained from parents of the included children. The study design conformed to the Revised Helsinki Declaration of Bioethics.

4 Results

Among the 400 CAP cases enrolled in this study, atypical pathogens were detected by multiplex PCR in 12/400 (3%) patients. Their mean age was 13.75 ± 15.46 months. Sixty percent of patients were males and 40% were females. A large proportion of the patients had severe pneumonia 104/400 (26%), of them 44 (11%) needed pediatric intensive care unit (PICU) admission. The detailed demographic and clinical characteristics of patients are summarized in Table 1.

Table 1 Demographic and clinical characteristics of children with community-acquired pneumonia, Cairo University Specialized Pediatric Hospital
Full size table

Bordetella pertussis was responsible for CAP in 8/400 (2%) patients, and Mycoplasma pneumoniae was determined as the cause of CAP in 4/400 (1%) patients in this study. None were positive for either C. pneumoniae or Legionella pneumophilia by PCR, as are shown in Table 2.

Table 2 The frequency of pathogen detection using the multiplex PCR among the CAP patients
Full size table

In this work, we did not encounter co-infection by more than one pathogen.

On studying the frequency of pathogen detection among different age stratums, Bordetella pertussis was detected in 8/104 (7.69%) infants ≤ 4 months, and pertussis-positive cases were significantly less than 4 months (P value ≤ 0.001). All cases of CAP caused by Mycoplasma pneumonia were among the age stratum > 4 months ≤ 59 months, as are shown in Table 3.

Table 3 Correlating the frequency of pathogen detection to different age groups
Full size table

Severe pneumonia was recorded in 50% of pertussis-positive patients with no need for PICU admission. Mycoplasma-positive cases did not record severe pneumonia or PICU admission.

On comparing clinical and radiological characteristics of pertussis-positive versus pertussis-negative cases in this study, the percentages of associated upper respiratory symptoms, vomiting, prolonged cough > 14 days, and interstitial infiltration were significantly related to pertussis-positive cases (P value was 0.001 for each). Mycoplasma-positive cases were more likely to have unilateral lung involvement with interstitial infiltration compared to mycoplasma-negative cases (P value was 0.03 and 0.01, respectively), as are demonstrated in Table 4.

Table 4 Comparing P value of associated clinical, laboratory, and radiographic findings among positive versus negative pertussis and mycoplasma cases
Full size table

5 Discussion

This study identified atypical pathogens as a potential etiologic agents in community-acquired pneumonia in 12/400 (3%) patients by the use of multiplex PCR. Bordetella pertussis was detected in 2% of cases, and it was responsible for CAP in 8/104 (7.69%) infants in the age stratum ≤ 4 months; Mycoplasma pneumoniae was detected in 1% of enrolled cases, all were among the age stratum > 4 months ≤ 59 months in 4/272 (1.47%) children.

Compared with pertussis-negative cases, pertussis-positive cases were younger and incompletely vaccinated against Bordetella pertussis, and this is in agreement with Sadiasa et al. [17] who found that Bordetella pertussis was the most common atypical pneumonia pathogen among hospitalized children. Higher frequencies of pertussis were recorded by Lassmann et al. [18] in Gabon, where they demonstrated that Bordetella pertussis caused 6% of cases of CAP in their study; all children who were tested positive for B. pertussis were not or only partially immunized. The tendency to infect young unvaccinated or incompletely vaccinated infants suggests the role for maternal pertussis immunization that can significantly increase antibody level for further reduction of disease burden during early infancy.

Pertussis-positive cases in this study were more likely to have been associated with upper respiratory symptoms, vomiting, and prolonged cough > 14 days. Similar results were recorded by Barger-Kamate et al. [19], and this is in concordance with the WHO recommended clinical case definition [20].

In the current study, Mycoplasma pneumoniae infection was detected in 1% of cases, which is relatively low, but in keeping with previous studies that reported the detection of Mycoplasma pneumoniae by PCR in 1.3% and 4.5% of children aged ≤ 5 years [21, 22]. Higher frequencies of detection of Mycoplasma pneumoniae were reported by Defilippi et al. and Hadi et al. who reported 12% and 10% detection rate, respectively [23, 24].

The propensity of Mycoplasma pneumoniae detection in the age stratum > 4 months ≤ 59 months in this study could be explained by the mean age of the study population that was 13.75 ± 15.46 months. This finding is supported by Lassmann et al. [18] in Gabon who found that all children who were tested positive for atypical pathogens were less than 5 years old.

Similar to what previously reported by Agarwal et al. [25], this study did not detect Chlamydia pneumoniae among cases with CAP. In contrast, Samransamruajkit et al. [26] in Thailand found that Chlamydia pneumoniae was responsible for 12.5% of cases of CAP in their study. The available literature supports a low prevalence of Chlamydia pneumoniae infection in children younger than 5 years, but it is an important cause of pneumonia among older children [27]. The rate of isolation of Chlamydia pneumoniae from acute lower respiratory tract infections in children ranges from 0 to 18% [3, 25, 28,29,30].

Despite that Legionella pneumophilia infection in hospitalized children with CAP has been reported in some studies [2, 31, 32], we did not detect legionella infection among enrolled cases in this study, and this could be explained by our exclusion criteria where we excluded all cases with underling chronic diseases or malignancies. It has been reported that the majority of children with Legionnaires’ disease have an underlying condition such as malignancy [33], renal or liver failure, diabetes, and other conditions that compromise the immune system [34].

There was no significant difference in clinical presentations or TLC between Mycoplasma pneumoniae-positive and Mycoplasma pneumoniae-negative cases, this is in agreement with Hadi et al. [24] in Iran and Lassmann et al. [18] in Gabon. Also, this was supported by Somer et al. who stated that a clinical diagnosis of infection by atypical bacteria remains elusive [28]. Chest X-ray of mycoplasma-positive cases showed a significant unilateral interstitial infiltration; this is in agreement with other studies [24, 27].

The present study recorded severe pneumonia in 26% of enrolled cases and PICU admission in 11% of cases. Severe pneumonia was encountered in 50% of pertussis-positive patients without the need for PICU admission. At the same time, mycoplasma-positive cases were not associated with severe pneumonia or PICU admission. These findings could be explained by the significantly younger age of pertussis-positive cases. This is consistent with Le Huong et al. [2] in Vietnam, where they found that the highest proportion of severe CAP infections occurred in children younger than 2 years, so the younger the child, the more likely that the atypical pathogen CAP will be severe.

5.1 Limitations of the study

Limiting this study was that its PCR panel did not include other atypical pathogens including respiratory viruses, which are common causes of lower respiratory tract infections. Furthermore, the sample was based on a pre-determined duration rather than calculating a minimum number of cases.

6 Conclusion and recommendations

In early infancy, Bordetella pertussis caused a significant proportion of hospitalized CAP cases; all were ≤ 4 months old and incompletely vaccinated. This finding could emphasize the role of maternal immunization in developing countries and the importance of complying with the schedule of the DTP vaccine.

References

  1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408–16.

    Article  Google Scholar 

  2. Le Huong P, Hien PT, Lan NT, Binh TQ, Tuan DM, Anh DD. First report on prevalence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-15 years. BMC Public Health. 2014;14:1304.

    Article  Google Scholar 

  3. Chen Z, Ji W, Wang Y, Yan Y, Zhu H, Shao X. Epidemiology and associations with climatic conditions of Mycoplasma pneumoniae and Chlamydophila pneumoniae infections among Chinese children hospitalized with acute respiratory infections. Ital J Pediatr. 2013;39:34.

    Article  Google Scholar 

  4. Principi N, Esposito S, Blasi F, Allegra L; Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001; 32:1281–1289.

  5. Zar HJ, Barnett W, Stadler A, Gardner-Lubbe S, Myer L, Nicol MP. Etiology of childhood pneumonia in a well vaccinated South African birth cohort: a nested case-control study of the Drakenstein Child Health Study. Lancet Respir Med. 2016;4:463–672.

    Article  Google Scholar 

  6. Muloiwa R, Dube FS, Nicol MP, Zar HJ, Hussey GD. Incidence and diagnosis of pertussis in South African children hospitalized with lower respiratory tract infection. Pediatr Infect Dis J. 2016;35:611–6.

    Article  Google Scholar 

  7. Winter K, Zipprich J, Harriman K, Murray EL, Gornbein J, Hammer SJ, et al. Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis. 2015;61:1099–106.

    Article  Google Scholar 

  8. Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385:430–40.

    Article  Google Scholar 

  9. Atkinson M, Lakhanpaul M, Smyth A, Vyas H, Weston V, Sithole J, et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax. 2007;62:1102–6.

    Article  Google Scholar 

  10. Cunha BA. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infect. 2006;12:12–24.

    Article  Google Scholar 

  11. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27–72.

    Article  CAS  Google Scholar 

  12. World Health Organization, Department of essential drugs and medicines policy. WHO Workshop on containment of antimicrobial resistance in Europe, 26-27 February 2004 in Wernigerode, Germany. Bundesgesundheitsblatt Gesundheitsforschung. Gesundheitsschutz. 2005;48:221-231. [cited 2018 July 11], Available at: https://link.springer.com/article/10.1007%2Fs00103-004-0983-4.

  13. Scott JA, Wonodi C, Moïsi JC, Deloria-Knoll M, DeLuca AN, Karron RA, et al. The definition of pneumonia, the assessment of severity, and clinical standardization in the Pneumonia Etiology Research for Child Health study. Clin Infect Dis. 2012;54:109–16.

    Article  Google Scholar 

  14. Ullberg M, Lüthje P, Mölling P, Strålin K, Özenci V. Broad-range detection of microorganisms directly from bronchoalveolar lavage specimens by PCR/electrospray ionization-mass spectrometry. PLoS One. 2017;12:e0170033.

    Article  Google Scholar 

  15. Park S, Oh KC, Kim KS, Song KT, Yoo KH, Shim YS, et al. Role of atypical pathogens and the antibiotic prescription pattern in acute bronchitis: a multicenter study in Korea. J Korean Med Sci. 2015;30:1446–14452.

    Article  CAS  Google Scholar 

  16. Fontana C, Favaro M, Favalli C. How liquid based microbiology can change the workflow in the microbiology laboratories. Adv Microbiol. 2013;3:504–10.

    Article  CAS  Google Scholar 

  17. Sadiasa A, Saito-Obata M, Dapat C. Bordetella pertussis infection in children with severe pneumonia, Philippines, 2012-2015. Vaccine. 2017;35:993–6.

    Article  Google Scholar 

  18. Lassmann B, Poetsoke M, Ninteretse B, Issifous S, Winkler S, Kremsner PG, et al. Community acquired pneumonia in children in Lambarene, Gabon. Am J Trop Med Hyg. 2008;79:109–14.

    Article  Google Scholar 

  19. Barger-Kamate B, Deloria Knoll M, Kagucia EW, Prosperi C, Baggett HC, Brooks WA, et al. Pertussis-associated pneumonia in infants and children from low- and middle-income countries participating in the PERCH study. Clin Infect Dis. 2016;63:S187–S96.

    Article  Google Scholar 

  20. World Health Organization. WHO-recommended surveillance standard of pertussis. [Cited 2017 May 29]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis_standards/en/.

  21. Meijer A, Dagnelie CF, De Jong JC, De Vries A, Bestebroer TM, Van Loon AM, et al. Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices. Eur J Epidemiol. 2000;16:1099–106.

    Article  CAS  Google Scholar 

  22. Elkholy A, Elkaraksy H, Fattouh A, Bazaraa H, Hegazy R, Abdelhalim M. Acute lower respiratory tract infection due to Chlamydia and Mycoplasma spp. in Egyptian children under 5 years of age. J Trop Pediatr. 2009;55:195–7.

    Article  Google Scholar 

  23. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med. 2008;102:1762–8.

    Article  Google Scholar 

  24. Hadi N, Kashef S, Moazzen M, Pour MS, Rezaei N. Survey of Mycoplasma pneumoniae in Iranian children with acute lower respiratory tract infections. Braz J Infect Dis. 2011;15:97–101.

    Article  Google Scholar 

  25. Agarwal J, Awasthi S, Rajput A, Tiwari M, Jain A. Atypical bacterial pathogens in community-acquired pneumonia in children: a hospital-based study. Trop Dr. 2009;39:109–11.

    Google Scholar 

  26. Samransamruajkit R, Jitchaiwat S, Wachirapaes W, Deerojanawong J, Sritippayawan S, Prapphal N. Prevalence of Mycoplasma and Chlamydia pneumonia in severe community-acquired pneumonia among hospitalized children in Thailand. Jpn J Infect Dis. 2008;61:36–9.

    PubMed  Google Scholar 

  27. Martinez Tagle M, Kogan R, Rojas P, Rubilar L, Vidal R, Paya E. Diagnosis of Chlamydia pneumoniae in community acquired pneumonia in children in Chile. Acta Paediatr. 2000;89:650–3.

    Article  CAS  Google Scholar 

  28. Somer A, Salman N, Yalçın I, Ağaçfidan A. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey. J Trop Pediatr. 2006;52:173–8.

    Article  Google Scholar 

  29. Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis. 2007;44:568–76.

    Article  Google Scholar 

  30. Marchello C, Dale AP, Thai TN, Han DS, Ebell MH. Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis. Ann Fam Med. 2016;14:552–66.

    Article  Google Scholar 

  31. Prapphal N, Suwanjutha S, Durongkaveroj P, Lochindarat S, Kunakorn M, Deerojanawong J, et al. Prevalence and clinical presentations of atypical pathogens infection in community acquired pneumonia in Thailand. J Med Assoc Thail. 2006;89:1412–9.

    Google Scholar 

  32. Maltezou HC, La-Scola B, Astra H, Constantopoulou I, Vlahou V, Kafetzis DA, et al. Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR. Scand J Infect Dis. 2004;36:639–42.

    PubMed  Google Scholar 

  33. Greenberg D, Chiou CC, Famigilleti R, Lee TC, Yu VL. Problem pathogens: pediatrics legionellosis - implications for improved diagnosis. Lancet Infect Dis. 2006;6:529–35.

    Article  Google Scholar 

  34. Che D, Campese C, Santa-Olalla P, Jacquier G, Bitar D, Bernillon P, et al. Sporadic community-acquired Legionnaires’ disease in France: a 2-year national matched case-control study. Epidemiol Infect. 2008;136:1684–90.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors would acknowledge all patients included in this study

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

Not applicable

Author information

Authors and Affiliations

  1. Department of Pediatrics, Faculty of Medicine, Cairo University, 2 Atteia Abd El Hadi St., El Maadi, Cairo, 11562, Egypt

    Noussa R. El Basha, Hala H. Shaaban & Hassan A. El Atroush

  2. Department of Clinical Pathology, Faculty of Medicine, Cairo University, 2 Atteia Abd El Hadi St., El Maadi, Cairo, 11562, Egypt

    May M. Sherif & Amani A. El Kholy

Authors
  1. Noussa R. El Basha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hala H. Shaaban
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hassan A. El Atroush
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. May M. Sherif
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amani A. El Kholy
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NREB, HHS, and HAEA have conducted, analyzed, and drafted the manuscript of this study. MMS and AAEK have performed the laboratory workup for this study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Noussa R. El Basha.

Ethics declarations

Ethics approval and consent to participate

This study was approved by Cairo University Clinical Research Ethics Committee, and informed verbal consents were obtained from parents of the included children. Informed verbal consent has been obtained because most of our patient guardian’s are uncomfortable with reading and writing and may be too embarrassed by the written consent process to participate in a research. This informed verbal consent has been approved by Cairo University Clinical Research Ethics Committee as it cover the basic elements of the consent process that include full disclosure of the nature of the research, adequate comprehension on the part of the potential participant, and the participant`s voluntary choice to participate. The study design conformed to the Revised Helsinki Declaration of Bioethics.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El Basha, N.R., Shaaban, H.H., El Atroush, H.A. et al. The use of multiplex PCR for the detection of atypical pathogens in Egyptian children with CAP: a high rate of Bordetella pertussis in early infancy. J. Egypt. Public. Health. Assoc. 94, 5 (2019). https://doi.org/10.1186/s42506-018-0003-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s42506-018-0003-4

Keywords

  • Community-acquired pneumonia
  • Children
  • Atypical pathogen
  • Pertussis